Accessibility Menu
 
Lucid Diagnostics logo

Lucid Diagnostics

(NASDAQ) LUCD

Current Price$1.25
Market Cap$167.81M
Since IPO (2021)-89%
5 YearN/A
1 Year-15%
1 Month-1%

Lucid Diagnostics Financials at a Glance

Market Cap

$167.81M

Revenue (TTM)

$4.40M

Net Income (TTM)

$53.28M

EPS (TTM)

$-0.90

P/E Ratio

-1.43

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.25

Volume

21,422

Open

$1.25

Previous Close

$1.25

Daily Range

$1.23 - $1.27

52-Week Range

$0.95 - $1.80

LUCD News

LUCD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lucid Diagnostics

Industry

Healthcare Equipment and Supplies

Employees

72

CEO

Lishan Aklog, MD

Headquarters

New York City, NY 10165, US

LUCD Financials

Key Financial Metrics (TTM)

Gross Margin

-68%

Operating Margin

-11%

Net Income Margin

-12%

Return on Equity

-331%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-69.93%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$167.81M

Shares Outstanding

131.10M

Volume

21.42K

Short Interest

0.00%

Avg. Volume

1.30M

Financials (TTM)

Gross Profit

$3.92M

Operating Income

$46.05M

EBITDA

$44.34M

Operating Cash Flow

$44.14M

Capital Expenditure

$646.00K

Free Cash Flow

$44.79M

Cash & ST Invst.

$22.36M

Total Debt

$21.25M

Lucid Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$1.21M

+3.3%

Gross Profit

$706.00K

-37.9%

Gross Margin

-58.30%

N/A

Market Cap

$167.81M

N/A

Market Cap/Employee

$2.33M

N/A

Employees

72

N/A

Net Income

$10.40M

+16.0%

EBITDA

$11.54M

+5.1%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$23.00M

+1516.1%

Accounts Receivable

$550.00K

+1310.3%

Inventory

$856.00K

+31.5%

Long Term Debt

$1.16M

-42.5%

Short Term Debt

$23.18M

+109.7%

Return on Assets

-1.00%

N/A

Return on Invested Capital

-1.78%

N/A

Free Cash Flow

$10.92M

-3.8%

Operating Cash Flow

$10.89M

-7.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
APYXApyx Medical Corporation
$3.48-1.42%
AVRAnteris Technologies Global Corp.
$5.60-4.92%
RPIDRapid Micro Biosystems, Inc.
$2.35-6.00%
RCELAVITA Medical, Inc.
$3.95-1.99%

Trending Stocks

Symbol / CompanyPricePrice Chg
SMCISuper Micro Computer
$20.53-0.33%
NVDANvidia
$172.70-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%

Questions About LUCD

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.